| MR编号 | SE/H/1797/001 |
|---|
| 药品名称 | Salmeterol/fluticasone Neutec |
|---|
| 活性成分 | - fluticasone propionate 100.0 µg
- salmeterol xinafoate 50.0 µg
|
|---|
| 剂型 | Inhalation powder, pre-dispensed |
|---|
| 上市许可持有人 | Neutec Inhaler Ireland Limited |
|---|
| 参考成员国 - 产品名称 | Sweden (SE) Salmeterol/fluticasone propionate Neutec |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Salmeterol/Fluticasonpropionat Wellnex 50 Mikrogramm/100 Mikrogramm einzeldosiertes Pulver zur Inhalation - Denmark (DK)
- Netherlands (NL)
Salmeterol/fluticasonpropionaat Neutec 50/100 microgram, inhalatiepoeder, voorverdeeld - Iceland (IS)
Salmeterol/Fluticasone Wellnex 50 míkróg/100 míkróg/skammt innöndunarduft, afmældir skammtar - United Kingdom (Northern Ireland) (XI)
- Norway (NO)
Salmeterol/Fluticasone Wellnex - Finland (FI)
- France (FR)
|
|---|
| 许可日期 | 2019/05/02 |
|---|
| 最近更新日期 | 2024/07/31 |
|---|
| 药物ATC编码 | - R03AK06 salmeterol and fluticasone
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|